MAR 19, 2015 12:00 PM PDT

Special Lecturer - Towards a Neuroscience of Bipolar Disorder Risk

Presented At Neuroscience
Speakers
  • Scientia Professor and Head of the School of Psychiatry, University of New South Wales
    Biography
      Philip Mitchell is Scientia Professor and Head of the School of Psychiatry at University of New South Wales in Sydney, Australia; Member, Australian National Health and Medical Research Council Research Committee; Vice-President (Governance), International Society for Bipolar Disorders; and Board Member, Black Dog Institute.

      His research and clinical interests are in bipolar disorder and depression, with a particular focus on: predictors of the development of bipolar disorder in at-risk individuals; molecular genetics of bipolar disorder; pharmacological and psychological treatments for bipolar disorder and depression; clinical phenomenology of bipolar disorder and depression; and neurostimulatory therapies for depression. Professor Mitchell has published over 450 peer-reviewed papers or book chapters and is lead investigator on an Australian NHMRC-funded Program Grant on depression and bipolar disorder. He serves on the editorial boards of ‘Psychiatric Genetics', ‘CNS Drugs', ‘CNS Spectrums', ‘Frontiers in Behavioral and Psychiatric Genetics', ‘Future Neurology', ‘International Journal of Bipolar Disorders', ‘Medicine Today' and ‘Therapeutic Advances in Psychopharmacology'.

      In 2002 he was awarded the Senior Research Award of the Royal Australian and New Zealand College of Psychiatrists (RANZCP). In 2004, he received the Founders Medal of the Australasian Society for Psychiatry Research. In 2008, he was invited to give the endowed Samuel Novey Lecture in Psychological Medicine at Johns Hopkins University, Department of Psychiatry and Behavioral Sciences. In the 2010 Australia Day honours list Professor Mitchell was appointed as a Member of the Order of Australia for service to medical education, particularly in the field of psychiatry, as an academic, researcher and practitioner, through contributions to the understanding, treatment and prevention of mental illnesses. In 2013 he was awarded the College Citation of the RANZCP for exceptional service to psychiatry.

    Abstract:

    There is growing interest internationally in elucidating the clinical and biological profile of those at high genetic risk to bipolar disorder (BD) so as to enable the development of targeted early intervention programs. This presentation will focus on the emerging findings from our group and others – highlighting both prospective and cross-sectional reports. Clinical studies are now converging in finding increased rates of both anxiety and behavioural disorders in this group, with three sites reporting that these disorders increase the risk of later development of affective disorders. Cross-sectional neuropsychological studies of first degree relatives of those with BD have previously suggested impairments in verbal learning and working memory, but prospective studies such as our own have not confirmed such findings, suggesting that the well-documented impairments in those with established BD may represent sequelae of the illness. Molecular genetic studies from our own work and a UK group have demonstrated an enrichment of BD polygenic risk alleles in young high risk individuals. Neuroimaging studies – both structural and functional – are now indicating differences compared to controls without any family history of mental illness. Our own initial fMRI study reported reduced inferior frontal gyrus (IFG) activation during response inhibition to emotional stimuli, suggesting a potential trait marker of vulnerability to BD. We have subsequently found, using dynamic causal modelling, that this impaired IFG activation appears to be due to a specific network disturbance suggesting dysfunction in the processes that support hierarchical relationships between emotion and cognitive control. Other groups have also reported functional and structural evidence implicating the IFG in those at high risk of BD. Our preliminary functional and structural (DTI) connectivity analyses are also indicating impaired connections between the IFG and other relevant brain regions.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources